Login / Signup

Dissecting causes for improved survival among patients with acute myeloid leukemia in two different eras receiving identical regimens in sequential randomized studies.

Ing Soo TiongJohn ReynoldsKenneth F BradstockJohn F SeymourAndrew H Weinull null
Published in: Blood cancer journal (2018)
Keyphrases
  • acute myeloid leukemia
  • double blind
  • open label
  • placebo controlled
  • phase iii
  • allogeneic hematopoietic stem cell transplantation
  • phase ii
  • case control
  • free survival
  • randomized controlled trial
  • study protocol